Conatus Pharmaceuticals (CNAT) null Earnings

2NovConfirmed
Mar 18
May 18
Aug 18
Nov 18
-0.2
-0.18
-0.16
-0.15

Details

Expected EPS
-0.15
Actual EPS
-0.152
Surprise EPS
-0
Surprise Percent
+1.33%

Description

Conatus Pharmaceuticals (CNAT) has reported earnings of -0.152 per share for .

0 Comments

Share your thoughts